SEC Form 4 · accession 0001209191-15-042229
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey T. Walsh
Officer — Chief Operating Officer
Period of report
May 11, 2015
Accepted (ET)
May 13, 2015 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 11, 2015 | M | 10,455 | $2.09 | A | 10,455 | D | |
| Common Stock | May 11, 2015 | M | 545 | $2.09 | A | 11,000 | D | |
| Common StockF2 | May 11, 2015 | S | 1,120 | $160.8035 | D | 9,880 | D | |
| Common StockF3 | May 11, 2015 | S | 2,593 | $161.9571 | D | 7,287 | D | |
| Common StockF4 | May 11, 2015 | S | 1,715 | $162.8321 | D | 5,572 | D | |
| Common StockF5 | May 11, 2015 | S | 1,328 | $164.0553 | D | 4,244 | D | |
| Common StockF6 | May 11, 2015 | S | 1,121 | $165.2362 | D | 3,123 | D | |
| Common StockF7 | May 11, 2015 | S | 1,901 | $166.4062 | D | 1,222 | D | |
| Common StockF8 | May 11, 2015 | S | 1,222 | $167.2585 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F9 | $2.09 | May 11, 2015 | M | 10,455 | D | — | Jul 13, 2021 | Common Stock | 10,455 | 60,733 | D |
| Stock Otpion (right to buy)F9 | $2.09 | May 11, 2015 | M | 545 | D | — | Jul 13, 2021 | Common Stock | 545 | 12,780 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 26, 2014.
- F2The range of prices for the transaction reported on this line was $160.41 to $161.41. The average weighted price was $160.8035. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range of prices for the transaction reported on this line was $161.43 to $162.43. The average weighted price was $161.9571. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range of prices for the transaction reported on this line was $162.44 to $163.32. The average weighted price was $162.8321. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The range of prices for the transaction reported on this line was $163.47 to $164.46. The average weighted price was $164.0553. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6The range of prices for the transaction reported on this line was $164.78 to $165.56. The average weighted price was $165.2362. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F7The range of prices for the transaction reported on this line was $166.01 to $166.95. The average weighted price was $166.4062. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F8The range of prices for the transaction reported on this line was $167.0250 to $167.52. The average weighted price was $167.2585. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F9This option vests over a four-year period, at a rate of twenty-five percent (25%) on May 16, 2012 and in 36 equal monthly installments thereafter.